Wegovy 2.4MG/0.75ML 4S
Ended Awarded
- Contract number
- SPE2DR26FARPR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $115,794
Award facts
- Contract value 100% obligated
- $115,793.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $115,793.56 to AmerisourceBergen Drug Corp for Wegovy 2.4mg/0.75ml (4-pack) on November 12, 2025, with completion anticipated by December 10, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio primarily with DLA Medical Supply Chain, delivering a wide range of pharmaceutical products and medical supplies including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. This award reflects the contractor's proven capability to fulfill federal medical procurement requirements and its role as a critical vendor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery of Wegovy, a GLP-1 receptor agonist medication, aligns with the company's demonstrated expertise in supplying specialized pharmaceutical products to federal military and veteran healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FARPR?
SPE2DR26FARPR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FARPR worth?
The government has obligated $115,794 on SPE2DR26FARPR.
Is contract SPE2DR26FARPR an order under another contract?
Yes. SPE2DR26FARPR is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FARPR competed?
The extent of competition for SPE2DR26FARPR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award